FROSINI MARIA

Office hours
-
Monday from 11:00 to 12:00Place: Studio del Docente - Polo Scientifico di San Miniato, stanza C_01_187 (ex stanza 10312) I piano, settore CNote: Previo appuntamento per telefono (0577235355) o per email (maria.frosini@unisi.it)
Please ask the Professor for an appointment by phone (+390577235355) or email (maria.frosini@unisi.it)
Contacts
0577235355 [int.5355] (Studio),0577232086 [int.2086] (Laboratorio),0577232087 [int.2087] (Laboratorio)
Curriculum Vitae
Teaching activities
Completion accademic year: 2025/2026
Completion accademic year: 2024/2025
Completion accademic year: 2023/2024
Research
Ultime pubblicazioni:
- Maramai, S., Saletti, M., Paolino, M., Giuliani, G., Cazzola, J., Spaiardi, P., et al. (2024). Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents. BIOORGANIC & MEDICINAL CHEMISTRY, 112 [10.1016/j.bmc.2024.117872]. - view more
- Filippelli, A., Ciccone, V., Del Gaudio, C., Simonis, V., Frosini, M., Tusa, I., et al. (2024). ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1871(7) [10.1016/j.bbamcr.2024.119810]. - view more
- Pifferi, A., Chiaino, E., Fernandez-Abascal, J., Bannon, A.C., Davey, G.P., Frosini, M., et al. (2024). Exploring the Regulation of Cytochrome P450 in SH-SY5Y Cells: Implications for the Onset of Neurodegenerative Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(13) [10.3390/ijms25137439]. - view more
- Mattioli, L.B., Frosini, M., Corazza, I., Fiorino, S., Zippi, M., Micucci, M., et al. (2024). Long COVID-19 gastrointestinal related disorders and traditional Chinese medicine: A network target-based approach. PHYTOTHERAPY RESEARCH, 38(5), 2323-2346 [10.1002/ptr.8163]. - view more
- Poggialini, F., Vagaggini, C., Brai, A., Pasqualini, C., Crespan, E., Maga, G., et al. (2023). Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme. PHARMACEUTICS, 15(2) [10.3390/pharmaceutics15020453]. - view more